Artigos com autorizações de acesso público - Ralph WeisslederSaiba mais
GeralNIHDFGDoDHHMISNSFAHACIHRFWFNSERCNSFEuropean CommissionRWJFV Foundation, USANSFCSCLJDRFNWOA*StarBHFPancreatic Cancer Action Network, USAHFSPFWOEMBLResearch Council of LithuaniaKWFDOEHSFFCTSwedish Research CouncilESRCMRCNIHRZonMwDoris Duke Charitable FoundationGovernment of SpainBMBFNMRCNational Research Foundation, SingaporeLeducq Foundation, USAAmerican Brain Tumor AssociationCanada First Research Excellence Fund
Não disponíveis em nenhum local: 13
Near-infrared fluorescence: application to in vivo molecular imaging
SA Hilderbrand, R Weissleder
Current opinion in chemical biology 14 (1), 71-79, 2010
Autorizações: US National Institutes of Health
Magnetic nanoparticle biosensors
JB Haun, TJ Yoon, H Lee, R Weissleder
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 2 (3 …, 2010
Autorizações: US National Institutes of Health
Integrated magneto-chemical sensor for on-site food allergen detection
HY Lin, CH Huang, J Park, D Pathania, CM Castro, A Fasano, ...
ACS nano 11 (10), 10062-10069, 2017
Autorizações: US National Institutes of Health
Nano‐SAR development for bioactivity of nanoparticles with considerations of decision boundaries
R Liu, R Rallo, R Weissleder, C Tassa, S Shaw, Y Cohen
Small 9 (9‐10), 1842-1852, 2013
Autorizações: US National Institutes of Health, Government of Spain
Cell tracking
J Grimm, MF Kircher, R Weissleder
Der Radiologe 47 (1), 25-33, 2007
Autorizações: German Research Foundation
A screening paradigm for the design of improved polymer-coated superparamagnetic iron oxide nanoparticles
S Chen, F Reynolds, L Yu, R Weissleder, L Josephson
Journal of Materials Chemistry 19 (35), 6387-6392, 2009
Autorizações: US National Institutes of Health
A novel method of imaging calcium urolithiasis using fluorescence
JL Figueiredo, CC Passerotti, T Sponholtz, HT Nguyen, R Weissleder
The Journal of urology 179 (4), 1610-1614, 2008
Autorizações: US National Institutes of Health
Automated molecular-image cytometry and analysis in modern oncology
R Weissleder, H Lee
Nature Reviews Materials 5 (6), 409-422, 2020
Autorizações: US Department of Defense, US National Institutes of Health
Synthese und In‐vivo‐Bildgebung eines 18F‐markierten PARP1‐Inhibitors mithilfe eines chemisch orthogonalen, Abfangreagens‐gestützten Hochdurchsatzverfahrens
T Reiner, EJ Keliher, S Earley, B Marinelli, R Weissleder
Angewandte Chemie 123 (8), 1963-1966, 2011
Autorizações: US National Institutes of Health
Diagnostic magnetic resonance technology
C Min, H Shao, D Issadore, M Liong, R Weissleder, H Lee
Point-of-Care Diagnostics on a Chip, 197-222, 2013
Autorizações: US National Institutes of Health
Chlorination of Arylaldehyde-Derived Arylsulfonylhydrazones with N-Chlorosuccinimide Leading to 1, 2, 4, 5-Tetrazine Derivatives
YZ Ji, HJ Li, Y Liu, YC Wu
Synthesis 52 (01), 69-74, 2020
Autorizações: National Natural Science Foundation of China
Multimodal Imaging and Therapy with Magnetofluorescent Nanoparticles
JR McCarthy, R Weissleder
Nanoplatform‐Based Molecular Imaging, 593-613, 2011
Autorizações: US National Institutes of Health
Nanoplasmonic Sensing Technologies for Molecular Analysis of Extracellular Vesicles
H Im, MH Jeong, T Son, J Min, R Weissleder, H Lee
2022 IEEE Sensors, 01-04, 2022
Autorizações: US National Institutes of Health
Disponíveis em algum local: 543
Imaging in the era of molecular oncology
R Weissleder, MJ Pittet
Nature 452 (7187), 580-589, 2008
Autorizações: US National Institutes of Health
Epigenetic memory in induced pluripotent stem cells
K Kim, A Doi, B Wen, K Ng, R Zhao, P Cahan, J Kim, MJ Aryee, H Ji, ...
Nature 467 (7313), 285-290, 2010
Autorizações: US National Institutes of Health, Howard Hughes Medical Institute
Identification of splenic reservoir monocytes and their deployment to inflammatory sites
FK Swirski, M Nahrendorf, M Etzrodt, M Wildgruber, V Cortez-Retamozo, ...
Science 325 (5940), 612-616, 2009
Autorizações: US National Institutes of Health
Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
H Ying, AC Kimmelman, CA Lyssiotis, S Hua, GC Chu, ...
Cell 149 (3), 656-670, 2012
Autorizações: US National Institutes of Health
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
JA Engelman, L Chen, X Tan, K Crosby, AR Guimaraes, R Upadhyay, ...
Nature medicine 14 (12), 1351-1356, 2008
Autorizações: US National Institutes of Health
New technologies for analysis of extracellular vesicles
H Shao, H Im, CM Castro, X Breakefield, R Weissleder, H Lee
Chemical reviews 118 (4), 1917-1950, 2018
Autorizações: US National Institutes of Health, National Medical Research Council, Singapore
Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor
H Im, H Shao, YI Park, VM Peterson, CM Castro, R Weissleder, H Lee
Nature biotechnology 32 (5), 490-495, 2014
Autorizações: US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.